Mitsubishi Ufj Trust & Banking Corp Agios Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $6.34 Million - $10.7 Million	-210,920 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $71,928 - $110,067	2,220 Added 1.06%	210,920 $6.83 Million
Q2 2019 Aug 07, 2019	SELL	$46.17 - $68.1 $127,429 - $187,955	-2,760 Reduced 1.31%	208,700 $10.4 Million
Q1 2019 May 13, 2019	SELL	$45.92 - $67.67 $138,678 - $204,363	-3,020 Reduced 1.41%	211,460 $14.3 Million
Q4 2018 Feb 12, 2019	SELL	$42.73 - $76.53 $1.01 Million - $1.8 Million	-23,570 Reduced 9.9%	214,480 $9.89 Million
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $312,481 - $400,902	-4,360 Reduced 1.8%	238,050 $18.4 Million
Q2 2018 Aug 10, 2018	SELL	$73.22 - $99.55 $658,980 - $895,950	-9,000 Reduced 3.58%	242,410 $20.4 Million
Q1 2018 May 11, 2018	BUY	$59.83 - $86.53 $15 Million - $21.8 Million	251,410 New	251,410 $20.6 Million

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.